RGNX Stock-Based Compensation
Regenxbio Inc · Stock-Based Compensation
RGNX Stock-Based Compensation
Latest reported$35.04Mperiod ending
RGNX Stock-Based Comp ($0.00 → $35.04M)
Annual stock-based compensation
High-resolution chart · PNG
RGNX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 34,563,000 | |
| 38,463,000 | |
| 40,267,000 | |
| 40,788,000 | |
| 38,808,000 | |
| 31,949,000 | |
| 26,854,000 | |
| 16,641,000 | |
| 10,605,000 | |
| 7,031,000 | |
| 2,921,000 | |
| 319,000 | |
| 0 |